Leading Tenectase 20 Injection (Tenecteplase) Supplier from INDIA to Washington, USA | City Drug Exporters
City Drug Exporters supplies Tenectase 20 Injection (Tenecteplase) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Tenectase 20 Injection (Tenecteplase) is a recombinant tissue-type plasminogen activator (rt-PA) used as a thrombolytic, or 'clot-busting, ' agent. It dissolves harmful blood clots in critical blood vessels. Its primary applications are treating acute ischemic stroke and ST-elevation myocardial infarction (STEMI). It is administered exclusively via intravenous (IV) injection in a hospital setting.
Mechanism of Action
Activates Plasminogen: Binds to fibrin and converts bound plasminogen to plasmin.
Fibrin Specificity: Targets the fibrin mesh of a clot with high specificity.
Dissolves Clots: Plasmin breaks down the fibrin matrix, dissolving the clot and restoring blood flow.
TNK Modification: Contains genetic modifications that enhance binding and resistance to inhibitors.
Pharmacokinetics :
Route of Administration: Intravenous (IV) push over 5 to 10 seconds.
Initial Half-Life: Ranges from 20 to 24 minutes.
Terminal Half-Life: Ranges from 90 to 130 minutes.
Plasma Clearance: Mean clearance of 99 to 119 mL/min.
Metabolism: Primarily metabolized by the liver.
Indications :
Acute Ischemic Stroke: Administered to dissolve clots and restore cerebral blood flow.
Acute Myocardial Infarction: Reduces mortality rates associated with acute STEMI.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
